The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders

Frontiers in Cellular Neuroscience

Volumn 7, Issue DEC, 2013, Pages

  Ford, Anthony P ^a   Undem, Bradley J ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AF 219; Afferent sensitization; Airways hyperreactivity; Cough; P2X3; Urinary symptoms; Visceral disorders

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINERGIC P2X RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2Y RECEPTOR;

ASTHMA; BRAIN FUNCTION; HUMAN; INFLAMMATORY PAIN; KNOCKOUT MOUSE; NEUROMUSCULAR FUNCTION; NOCICEPTION; NONHUMAN; OVERACTIVE BLADDER; RESPIRATORY TRACT DISEASE; REVIEW; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE EXCITABILITY; SOMATOSENSORY SYSTEM; URINARY TRACT DISEASE; VISCERAL PAIN;

EID: 84891050921     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00267     Document Type: Review

References (77)

1. Abdulqawi, R., Dockry, R., Holt, K., Woodcock, A., Layton, G., McCarthy, B., et al. (2013). Inhibition of ATP-gated P2X3 channels by AF-219: an effective antitussive mechanism in chronic cough. Proceedings of the European Respiratory Society Annual Congress, abstract 1965.
2. Basbaum, A. I., Bautista, D. M., Scherrer, G., and Julius, D. (2009). Cellular and molecular mechanisms of pain. Cell 139, 267-284. doi: 10.1016/j.cell.2009.09.028
3. Basoglu, O. K., Pelleg, A., Essilfie-Quaye, S., Brindicci, C., Barnes, P. J., and Kharitonov, S. A. (2005). Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 128, 1905-1909. doi: 10.1378/chest. 128.4.1905
4. Beijer, S., Gielisse, E. A., Hupperets, P. S., van den Borne, B. E., van den Beuken-van Everdingen, M., Nijziel, M. R., et al. (2007). Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients. Invest. New Drugs 25, 571-579. doi: 10.1007/s10637-007-9076-1
5. Bland-Ward, P. A., and Humphrey, P. P. (1997). Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br. J. Pharmacol. 122, 365-371. doi: 10.1038/sj.bjp.0701371
6. Bleehen, T., Hobbiger, F., and Keele, C. A. (1976). Identification of algogenic substances in human erythrocytes. J. Physiol. 262, 131-149.
7. Bleehen, T., and Keele, C. A. (1977). Observations on the algogenic actions of adenosine compounds on the human skin blister base preparation. Pain 3, 367-377. doi: 10.1016/0304-3959(77)90066-5
8. Burgess, G., and Williams, D. (2010). The discovery and development of analgesics: new mechanisms, new modalities. J. Clin. Invest. 120, 3753-3759. doi: 10.1172/jci43195
9. Burnstock, G. (2012). Discovery of purinergic signalling, the initial resistance and current explosion of interest. Br. J. Pharmacol. 167, 238-255. doi: 10.1111/j.1476-5381.2012.02008.x
10. Burnstock, G. (2013). The paton lecture: purinergic signalling: from discovery to current developments. Exp. Physiol. doi: 10.1113/expphysiol.2013.071951. [Epub ahead of print].
11. Burnstock, G., Brouns, I., Adriaensen, D., and Timmermans, J. P. (2012). Purinergic signaling in the airways. Pharmacol. Rev. 64, 834-868. doi: 10.1124/pr.111.005389
12. Cherkas, P. S., Dostrovsky, J. O., and Sessle, B. J. (2012). Activation of peripheral P2X receptors is sufficient to induce central sensitization in rat medullary dorsal horn nociceptive neurons. Neurosci. Lett. 526, 160-163. doi: 10.1016/j.neulet. 2012.08.007
13. Cicko, S., Lucattelli, M., Müller, T., Lommatzsch, M., De Cunto, G., Cardini, S., et al. (2010). Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J. Immunol. 185, 688-697. doi: 10. 4049/jimmunol.0904042
14. Cockayne, D. A., Dunn, P. M., Zhong, Y., Rong, W., Hamilton, S. G., Knight, G. E., et al. (2005). P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol. 567, 621-639. doi: 10.1113/jphysiol.2005.088435
15. Collier, H. O., James, G. W., and Schneider, C. (1966). Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'triphosphate. Nature 212, 411-412. doi: 10.1038/212411a0
16. Collins, V. M., Daly, D. M., Liaskos, M., McKay, N. G., Sellers, D., Chapple, C., et al. (2013). OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium. BJU Int. 112, 1018-1026. doi: 10.1111/bju.12266
17. Cook, S. P., and McCleskey, E. W. (2002). Cell damage excites nociceptors through release of cytosolic ATP. Pain 95, 41-47. doi: 10.1016/s0304-3959(01)00372-4
18. Coutts, A. A., Jorizzo, J. L., Eady, R. A., Greaves, M. W., and Burnstock, G. (1981). Adenosine triphosphate-evoked vascular changes in human skin: mechanism of action. Eur. J. Pharmacol. 76, 391-401. doi: 10.1016/0014-2999(81) 90110-2
19. de Groat, W. C. (1997). A neurologic basis for the overactive bladder. Urology 50(Suppl. 6A), 36-52; discussion 53-56. doi: 10.1016/s0090-4295(97)00587-6
20. de Groat, W. C., and Wickens, C. (2013). Organization of the neural switching circuitry underlying reflex micturition. Acta Physiol. (Oxf.) 207, 66-84. doi: 10. 1111/apha.12014
21. Ferguson, D. R., Kennedy, I., and Burton, T. J. (1997). ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J. Physiol. 505, 503-511. doi: 10.1111/j.14697793.1997.503bb.x
22. Ford, A. P. (2012). In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal. 8(Suppl. 1), 3-26. doi: 10.1007/s11302-011-9271-6
23. Ford, A. P., and Cockayne, D. A. (2011). ATP and P2X purinoceptors in urinary tract disorders. Handb. Exp. Pharmacol. 202, 485-526. doi: 10.1007/978-3-642-16499-6_22
24. Ford, A. P., Smith, S. A., and Dillon, M. P. (2013). Pharmadynamic (PD) and pharmacokinetic (PK) properties of AF-219: first in class, selective, clinical P2X3 antagonist in development for chronic pain and related conditions. FASEB J. 27, (Meeting Abstract Supplement) 887.5.
25. Fowler, C. J., Griffiths, D., and de Groat, W. C. (2008). The neural control of micturition. Nat. Rev. Neurosci. 9, 453-466. doi: 10.1038/nrn2401
26. Fox, A. J., Barnes, P. J., Urban, L., and Dray, A. (1993). An in vitro study of the properties of single vagal afferents innervating guinea-pig airways. J. Physiol. 469, 21-35. doi: 10.1016/0143-4179(93)90115-q
27. Fox, A. J., Urban, L., Barnes, P. J., and Dray, A. (1995). Effects of capsazepine against capsaicin- and proton-evoked excitation of single airway C-fibres and vagus nerve from the guinea-pig. Neuroscience 67, 741-752. doi: 10.1016/03064522(95)00115-y
28. Gever, J. R., Soto, R., Henningsen, R. A., Martin, R. S., Hackos, D. H., Panicker, S., et al. (2010). AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br. J. Pharmacol. 160, 1387-1398. doi: 10.1111/j.1476-5381. 2010.00796.x
29. Giniatullin, R., Nistri, A., and Fabbretti, E. (2008). Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol. Neurobiol. 37, 83-90. doi: 10.1007/s12035-0088020-5
30. Gnanasekaran, A., Sundukova, M., Hullugundi, S., Birsa, N., Bianchini, G., Hsueh, Y. P., et al. (2013). Calcium/calmodulin-dependent serine protein kinase (CASK) is a new intracellular modulator of P2X3 receptors. J. Neurochem. 126, 102-112. doi: 10.1111/jnc.12272
31. Gnanasekaran, A., Sundukova, M., van den Maagdenberg, A. M., Fabbretti, E., and Nistri, A. (2011). Lipid rafts control P2X3 receptor distribution and function in trigeminal sensory neurons of a transgenic migraine mouse model. Mol. Pain 7:77. doi: 10.1186/1744-8069-7-77
32. Gu, J. G., and MacDermott, A. B. (1997). Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 389, 749-753. doi: 10.1038/39639
33. Gum, R. J., Wakefield, B., and Jarvis, M. F. (2012). P2X receptor antagonists for pain management: examination of binding and physicochemical properties. Purinergic Signal. 8, 41-56. doi: 10.1007/s11302-011-9272-5
34. Hamilton, S. G., McMahon, S. B., and Lewin, G. R. (2001). Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J. Physiol. 534, 437-445. doi: 10.1111/j.1469-7793.2001.00437.x
35. Hamilton, S. G., Wade, A., and McMahon, S. B. (1999). The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat. Br. J. Pharmacol. 126, 326-332. doi: 10.1038/sj.bjp.07 02258
36. Hamilton, S. G., Warburton, J., Bhattacharjee, A., Ward, J., and McMahon, S. B. (2000). ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia. Brain 123, 1238-1246. doi: 10. 1093/brain/123.6.1238
37. Haskell, C. M., Mendoza, E., Pisters, K. M., Fossella, F. V., and Figlin, R. A. (1998). Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer. Invest. New Drugs 16, 81-85. doi: 10.1023/A:1006018610986
38. Hilliges, M., Weidner, C., Schmelz, M., Schmidt, R., Ørstavik, K., Torebjörk, E., et al. (2002). ATP responses in human C nociceptors. Pain 98, 59-68. doi: 10. 1016/s0304-3959(01)00469-9
39. Hurt, C. M., Wang, L., Xu, J., Sterious, W., and Pelleg, A. (1994). Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs. II. Vagal afferent traffic. Am. J. Physiol. 267(3 Pt. 2), H1093-H1097.
40. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M. A., Muskens, F., et al. (2007). Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13, 913-919. doi: 10. 1038/nm1617
41. Jahangir, A., Alam, M., Carter, D. S., Dillon, M. P., Bois, D. J., Ford, A. P., et al. (2009). Identification and SAR of novel diaminopyrimidines. Part 2: the discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain. Bioorg. Med. Chem. Lett. 19, 1632-1635. doi: 10.1016/j. bmcl.2009.01.097
42. Jarvis, M. F., Burgard, E. C., McGaraughty, S., Honore, P., Lynch, K., Brennan, T. J., et al. (2002). A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U S A 99, 17179-17184. doi: 10.1073/pnas. 252537299
43. Kamei, J., and Takahashi, Y. (2006). Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs. Eur. J. Pharmacol. 547, 160-164. doi: 10.1016/j.ejphar.2006.07.034
44. Kamei, J., Takahashi, Y., Yoshikawa, Y., and Saitoh, A. (2005). Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity. Eur. J. Pharmacol. 528, 158-161. doi: 10.1016/j.ejphar.2005.10.030
45. Keele, C. A., and Armstrong, D. (1964). Substances Producing Pain and Itch. London: Edward Arnold.
46. Khakh, B. S., and North, R. A. (2006). P2X receptors as cell-surface ATP sensors in health and disease. Nature 442, 527-532. doi: 10.1038/nature04886
47. Koeppen, M., Di Virgilio, F., Clambey, E. T., and Eltzschig, H. K. (2011). Purinergic regulation of airway inflammation. Subcell. Biochem. 55, 159-193. doi: 10. 1007/978-94-007-1217-1_7
48. Kwong, K., Kollarik, M., Nassenstein, C., Ru, F., and Undem, B. J. (2008). P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L858-L865. doi: 10.1152/ajplung.90360.2008
49. McAlexander, M. A., Myers, A. C., and Undem, B. J. (1999). Adaptation of guinea-pig vagal airway afferent neurones to mechanical stimulation. J. Physiol. 521(Pt. 1), 239-247. doi: 10.1111/j.1469-7793.1999.00239.x
50. Mork, H., Ashina, M., Bendtsen, L., Olesen, J., and Jensen, R. (2003). Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur. J. Pain 7, 145-153. doi: 10.1016/s1090-3801(02)00096-4
51. Morrison, J. (1999). The activation of bladder wall afferent nerves. Exp. Physiol. 84, 131-136. doi: 10.1080/003655999750016348
52. Myers, A. C., Undem, B. J., and Weinreich, D. (1991). Influence of antigen on membrane properties of guinea-pig bronchial ganglion neurons. J. Appl. Physiol. 71, 970-976.
53. Namasivayam, S., Eardley, I., and Morrison, J. F. (1998). A novel in vitro bladder pelvic nerve afferent model in the rat. Br. J. Urol. 82, 902-905. doi: 10.1046/j.1464-410x.1998.00867.x
54. Namasivayam, S., Eardley, I., and Morrison, J. F. (1999). Purinergic sensory neurotransmission in the urinary bladder: an in vitro study in the rat. BJU Int. 84, 854-860. doi: 10.1046/j.1464-410x.1999.00310.x
55. Nassenstein, C., Taylor-Clark, T. E., Myers, A. C., Ru, F., Nandigama, R., Bettner, W., et al. (2010). Phenotypic distinctions between neural crest and placodal derived vagal C-fibres in mouse lungs. J. Physiol. 588(Pt. 23), 4769-4783. doi: 10. 1113/jphysiol.2010.195339
56. North, R. A., and Jarvis, M. F. (2013). P2X receptors as drug targets. Mol. Pharmacol. 83, 759-769. doi: 10.1124/mol.112.083758
57. Pandita, R. K., and Andersson, K. E. (2002). Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J. Urol. 168, 1230-1234. doi: 10.1016/s0022-5347(05)64631-9
58. Parada, C. A., Reichling, D. B., and Levine, J. D. (2005). Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. Pain 113, 185-190. doi: 10.1016/j.pain.2004.10.021
59. Pellegrino, R., Wilson, O., Jenouri, G., and Rodarte, J. R. (1996). Lung mechanics during induced bronchoconstriction. J. Appl. Physiol. (1985) 81, 964-975.
60. Pollak, K. A., Swenson, J. D., Vanhaitsma, T. A., Hughen, R. W., Jo, D., Light, K.C., et al. (2013). Exogenously appliedmuscle metabolites synergisticallyevoke sensations of muscle fatigue and pain in human subjects. Exp. Physiol. doi: 10. 1113/expphysiol.2013.075812. [Epub ahead of print].
61. Prado, F. C., Araldi, D., Vieira, A. S., Oliveira-Fusaro, M. C., Tambeli, C. H., and Parada, C. A. (2013). Neuronal P2X3 receptor activation is essential to the hyperalgesia induced by prostaglandins and sympathomimetic amines released during inflammation. Neuropharmacology 67, 252-258. doi: 10.1016/j. neuropharm.2012.11.011
62. Riccio, M. M., Myers, A. C., and Undem, B. J. (1996). Immunomodulation of afferent neurons in guinea-pig isolated airway. J. Physiol. 491, 499-509.
63. Rong, W., Spyer, K. M., and Burnstock, G. (2002). Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J. Physiol. 541, 591-600. doi: 10.1113/jphysiol.2001.013469
64. Serrano, A., Mo, G., Grant, R., Paré, M., O'Donnell, D., Yu, X. H., et al. (2012). Differential expression and pharmacology of native P2X receptors in rat and primate sensory neurons. J. Neurosci. 32, 11890-11896. doi: 10.1523/jneurosci. 0698-12.2012
65. Shinoda, M., Ozaki, N., Asai, H., Nagamine, K., and Sugiura, Y. (2005). Changes in P2X3 receptor expression in the trigeminal ganglion following monoarthritis of the temporomandibular joint in rats. Pain 116, 42-51. doi: 10.1016/j.pain.2005.03.042
66. Smith, S. A., Black, D., Song, D., and Ford, A. P. (2013). A novel method to estimate AF-219 levels in bladder interstitium derived from drug excreted into the urine. FASEB J. 27, (Meeting Abstract Supplement) 1103.3.
67. Sun, Q., Dong, L., Zhang, G., Ford, A. P., and Rong, W. F. (2012). P2X3 receptor antagonism attenuates pelvic afferent discharge and visceromotor responses to urinary bladder distension in naïve and cyclophosphamide treated rats. Proceedings of 13th IASP World Congress of Pain, abstract 412.
68. Tsuda, M., Koizumi, S., Kita, A., Shigemoto, Y., Ueno, S., and Inoue, K. (2000). Mechanical allodynia caused by intraplanar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor siganling in capsaicin-insensitive primary afferent neurons. J. Neurosci. 20, RC90.
69. Undem, B. J., Chuaychoo, B., Lee, M. G., Weinreich, D., Myers, A. C., and Kollarik, M. (2004). Subtypes of vagal afferent C-fibres in guinea-pig lungs. J. Physiol. 556, 905-917. doi: 10.1113/jphysiol.2003.060079
70. Vlaskovska, M., Kasakov, L., Rong, W., Bodin, P., Bardini, M., Cockayne, D. A., et al. (2001). P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J. Neurosci. 21, 5670-5677.
71. Volonté, C., and Burnstock, G. (2013). P2X3 receptor: a novel 'CASKade' of signaling? J. Neurochem. 126, 1-3. doi: 10.1111/jnc.12282
72. Wang, E. C., Lee, J. M., Ruiz, W. G., Balestreire, E. M., von Bodungen, M., Barrick, S., et al. (2005). ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J. Clin. Invest. 115, 2412-2422. doi: 10.1172/jci 24086
73. Weigand, L. A., Ford, A. P., and Undem, B. J. (2012). A role for ATP in bronchoconstriction-induced activation of guinea pig vagal intrapulmonary C-fibres. J. Physiol. 590, 4109-4120. doi: 10.1113/jphysiol.2012.2 33460
74. Yu, Y., and de Groat, W. C. (2008). Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment. Am. J. Physiol. Renal Physiol. 294, F1146-F1156. doi: 10.1152/ajprenal.00592.2007
75. Yu, Y., and de Groat, W. C. (2010). Effects of stimulation of muscarinic receptors on bladder afferent nerves in the in vitro bladder-pelvic afferent nerve preparation of the rat. Brain Res. 1361, 43-53. doi: 10.1016/j.brainres.2010.09.018
76. Zagorodnyuk, V. P., Brookes, S. J., Spencer, N. J., and Gregory, S. (2009). Mechanotransduction and chemosensitivity of two major classes of bladder afferents with endings in the vicinity to the urothelium. J. Physiol. 587, 3523-3538. doi: 10.1113/jphysiol.2009.172577
77. Zagorodnyuk, V. P., Gibbins, I. L., Costa, M., Brookes, S. J., and Gregory, S. J. (2007). Properties of the major classes of mechanoreceptors in the guinea pig bladder. J. Physiol. 585, 147-163. doi: 10.1016/j.autneu.2007.06.090